LSTA - Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
Story updates
01:34:42 PM UTC
SquawkNews
Lisata Therapeutics closed a stock-for-stock acquisition of Marea Therapeutics and lined up a $225 million PIPE financing in Series C non-voting convertible preferred shares. The merger restructures ownership, with former Marea holders poised to own a majority post-PIPE, and is intended to expand L…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.